Skip to main content

Table 3 Publications included for this analysis along with their concluding results regarding the rates of detection, accuracy, sensitivity, false negative and upstaging as well as the false negative rates associated with lymphatic mapping and sentinel node biopsy for colon cancer.

From: Could lymphatic mapping and sentinel node biopsy provide oncological providence for local resectional techniques for colon cancer? A review of the literature

Lead Author

Year

Journal

Detection

Rate

Accuracy

Rate

Sensitivity

Rate

False Negative

Rate

Negative Predictive

Value

Upstaging

Rate

Saha (a)[47]

2000

Ann Surg Oncol

99

96

91

9

Ns

18

Wiese (a)[48]

2000

Arch Pathol Lab Med

99

96

91

9

ns

ns

Waters (b)[49]

2000

Am Surg

91

100

100

0

100

6

Bilchik (c)[50]

2001

J Clin Oncol

100

100

100

0

100

50

Paramo (d)[51]

2001

Am J Surg

71

100

100

0

100

11

Wood (a)+(c)[52]

2001

Ann Surg Oncol

96

95

88

12

ns

25

Wood (c)[53]

2001

Surg Endosc

100

100

100

0

100

9

Saha (a)+(c)[54]

2001

Ann Surg Oncol

98

96

90

10

95

14

Esser [55]

2001

Dis Colon Rectum

58

94

67

33

94

7

Bendavid [56]

2002

J Surg Oncol

90

94

95

5

91

42

Paramo (d)[57]

2002

Ann Surg Oncol

82

98

93

7

97

11

Wood (c)[58]

2002

J GastroInt Surg

97

95

92

8

ns

24

Bilchik (c)[59]

2002

Eur J Cancer

97

95

91

5

ns

24

Kitagawa [60]

2002

Dis Colon Rectum

91

92

82

18

88

ns

Feig (e)[61]

2002

Am J Surg

98

79

38

62

76

8

Broderick-Villa [62]

2002

Cancer J

92

79

50

50

73

0

Tsioulias (c)[63]

2002

Am Surg

100

93

67

33

ns

15

Nastro [64]

2002

Tumori

75

100

100

0

100

ns

Bilchik (c)[65]

2003

Cancer Control

100

93

91

9

ns

14

Cox [66]

2003

Curr Surg

100

100

100

0

100

29

Bilchik (c)[67]

2003

J Clin Oncol

96

96

92

8

ns

29

Turner (c)[68]

2003

Archives Path

82

92

87

13

ns

29

Trocha (a)+(c)[69]

2003

J GastroInt Surg

98

95

84

16

93

21

Veihl [70]

2003

World J Surg

87

78

50

22

71

11

Levine (b)[71]

2003

J GastroInt Surg

92

ns

50

ns

86

ns

Saha (a)[72]

2004

Dis Colon Rectum

99

ns

88

12

ns

13

Dan (a)[73]

2004

Arch Surg

99

96

86

16

ns

5

Braat [21]

2004

Eur J Surg Oncol

94

97

80

20

92

3

Bertoglio [74]

2004

J Surg Oncol

95

92

78

22

88

ns

Read [75]

2004

Dis Colon Rectum

79

97

25

75

ns

3

Patten (e)[76]

2004

Cancer

98

89

83

17

76

20

Bertagnolli [77]

2004

Ann Surg

92

80

46

54

75

0

Saha (a)[78]

2004

Ann Surg Oncol

100

95

84

16

93

5

Saha (a)[79]

2004

Semin Oncol

100

96

92

8

ns

13

Bembenek (f)[80]

2005

World J Surg

85

ns

92

8

95

26

Codnignola [81]

2005

JJ Clin Oncol

100

ns

72

28

70

37

Dahl [82]

2005

Eur J Surg Oncol

100

92

83

17

91

ns

Bilchik (a)+(c)[83]

2006

Arch Surg

100

95

88

12

ns

23

Tuech [84]

2006

Eur J Surg Oncol

97

94

91

9

ns

ns

Saha (a)[85]

2006

Am J Surg

98

96

90

10

93

ns

Kelder (g)[86]

2006

Scand J Gastroenterol

97

93

86

14

89

33

Thomas (b)[87]

2006

Am Surg

93

20

46

54

73

5

Covarelli [88]

2006

Am Surg

95

95

86

14

ns

8

Kelder (g)[89]

2007

Int J Col Dis

97

96

89

11

93

ns

Bianchi [90]

2007

Surg End

100

95

83

17

94

9

Murawa [91]

2007

Acta Chir Belg

93

84

83

17

ns

8

Bembenek (f)[92]

2007

Ann Surg

85

86

54

46

80

21

Sandrucci [93]

2007

J Surg Oncol

100

91

92

9

ns

11

Tiffet [94]

2007

Dis Colon Rectum

92

81

80

20

74

ns

Lim (e)[95]

2008

Ann Surg Oncol

99

83

59

41

78

ns

Kusano [96]

2008

Digestive Surgery

88.5

82.6

33

67

81

ns

Quadros [97]

2008

J Surg Oncol

91

80

67

33

67

25

  1. The definitions for each are contained in the text. All rates are %; ns denotes data neither stated within nor readily derived from the results presented within the publication. Note: several centers have published more than one series without declaring overlap of their patient cohorts – such publications are flagged by the center of origin by the inclusion of letter subscript as follows: (a) McLaren Regional Center, Michigan, USA; (b) Wake Forest, North Carolina, USA; (c) John Wayne Cancer Institute, California, USA; (d) Mount Sinai, Miami Beach, USA; (e) MD Anderson, Texas; (f) Charité-University Medicine Berlin, Berlin, Germany; (g) University Medical Center Groningen, The Netherlands. Table 4,5 and 6 also follow a similar format.